ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Loxoprofen API (Sodium Salt) Market Research Report 2026
Published Date: 2026-01-21
|
Report Code: QYRE-Auto-11Y20028
Home | Market Reports
Global Loxoprofen API Sodium Salt Market Outlook In Depth Analysis Forecast to 2031
BUY CHAPTERS

Global Loxoprofen API (Sodium Salt) Market Research Report 2026

Code: QYRE-Auto-11Y20028
Report
2026-01-21
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Daiichi Sankyo
Anlon Healthcare
Metrochem
Shinpoong Pharm
Apeloa Pharmaceutical
Luoxin Pharmaceutical
Zhejiang Starry Pharmaceutical
Dongyue Pharma
Hunan Jiudian Hongyang

Loxoprofen API (Sodium Salt) Market Size

The global Loxoprofen API (Sodium Salt) market was valued at US$ 73.68 million in 2025 and is anticipated to reach US$ 98 million by 2032, at a CAGR of 4.2% from 2026 to 2032.

Loxoprofen API (Sodium Salt) Market

Loxoprofen API (Sodium Salt) Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Loxoprofen API (Sodium Salt) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Loxoprofen sodium salt is an organic compound. Chemically, it is named sodium 2 - [4 - (2 - oxocyclopentyl - 1 - ylmethyl)phenyl]propionate dihydrate. Structurally, it belongs to the arylpropionic acid - type compounds. This structure endows it with anti - inflammatory, analgesic, and antipyretic pharmacological activities. It is the primary starting material for the synthesis of loxoprofen sodium pharmaceutical formulations and provides the crucial chemical basis for the drug to exert its therapeutic effects.
The North American market for Loxoprofen API (Sodium Salt) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Loxoprofen API (Sodium Salt) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Loxoprofen API (Sodium Salt) include Daiichi Sankyo, Anlon Healthcare, Metrochem, Shinpoong Pharm, Apeloa Pharmaceutical, Luoxin Pharmaceutical, Hunan Jiudian Hongyang, Zhejiang Starry Pharmaceutical, Dongyue Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Loxoprofen API (Sodium Salt) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Loxoprofen API (Sodium Salt). The Loxoprofen API (Sodium Salt) market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Loxoprofen API (Sodium Salt) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Loxoprofen API (Sodium Salt) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Loxoprofen API (Sodium Salt) Market Report

Report Metric Details
Report Name Loxoprofen API (Sodium Salt) Market
Accounted market size in 2025 US$ 73.68 million
Forecasted market size in 2032 US$ 98 million
CAGR 4.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Purity ≥99%
  • Purity <99%
by Application
  • Oral Preparations
  • Topical Preparations
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Daiichi Sankyo, Anlon Healthcare, Metrochem, Shinpoong Pharm, Apeloa Pharmaceutical, Luoxin Pharmaceutical, Hunan Jiudian Hongyang, Zhejiang Starry Pharmaceutical, Dongyue Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Loxoprofen API (Sodium Salt) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Loxoprofen API (Sodium Salt) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Loxoprofen API (Sodium Salt) Market growing?

Ans: The Loxoprofen API (Sodium Salt) Market witnessing a CAGR of 4.2% during the forecast period 2026-2032.

What is the Loxoprofen API (Sodium Salt) Market size in 2032?

Ans: The Loxoprofen API (Sodium Salt) Market size in 2032 will be US$ 98 million.

Who are the main players in the Loxoprofen API (Sodium Salt) Market report?

Ans: The main players in the Loxoprofen API (Sodium Salt) Market are Daiichi Sankyo, Anlon Healthcare, Metrochem, Shinpoong Pharm, Apeloa Pharmaceutical, Luoxin Pharmaceutical, Hunan Jiudian Hongyang, Zhejiang Starry Pharmaceutical, Dongyue Pharma

What are the Application segmentation covered in the Loxoprofen API (Sodium Salt) Market report?

Ans: The Applications covered in the Loxoprofen API (Sodium Salt) Market report are Oral Preparations, Topical Preparations

What are the Type segmentation covered in the Loxoprofen API (Sodium Salt) Market report?

Ans: The Types covered in the Loxoprofen API (Sodium Salt) Market report are Purity ≥99%, Purity <99%

1 Loxoprofen API (Sodium Salt) Market Overview
1.1 Product Definition
1.2 Loxoprofen API (Sodium Salt) by Type
1.2.1 Global Loxoprofen API (Sodium Salt) Market Value by Type: 2025 vs 2032
1.2.2 Purity ≥99%
1.2.3 Purity <99%
1.3 Loxoprofen API (Sodium Salt) by Application
1.3.1 Global Loxoprofen API (Sodium Salt) Market Value by Application: 2025 vs 2032
1.3.2 Oral Preparations
1.3.3 Topical Preparations
1.4 Global Loxoprofen API (Sodium Salt) Market Size Estimates and Forecasts
1.4.1 Global Loxoprofen API (Sodium Salt) Revenue 2021–2032
1.4.2 Global Loxoprofen API (Sodium Salt) Sales 2021–2032
1.4.3 Global Loxoprofen API (Sodium Salt) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Loxoprofen API (Sodium Salt) Market Competition by Manufacturers
2.1 Global Loxoprofen API (Sodium Salt) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Loxoprofen API (Sodium Salt) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Loxoprofen API (Sodium Salt) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Loxoprofen API (Sodium Salt), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Loxoprofen API (Sodium Salt), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Loxoprofen API (Sodium Salt), Product Types and Applications
2.7 Global Key Manufacturers of Loxoprofen API (Sodium Salt), Date of Entry into the Industry
2.8 Global Loxoprofen API (Sodium Salt) Market Competitive Situation and Trends
2.8.1 Global Loxoprofen API (Sodium Salt) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Loxoprofen API (Sodium Salt) Players Market Share by Revenue
2.8.3 Global Loxoprofen API (Sodium Salt) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Loxoprofen API (Sodium Salt) Market Scenario by Region
3.1 Global Loxoprofen API (Sodium Salt) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Loxoprofen API (Sodium Salt) Sales by Region: 2021–2032
3.2.1 Global Loxoprofen API (Sodium Salt) Sales by Region: 2021–2026
3.2.2 Global Loxoprofen API (Sodium Salt) Sales by Region: 2027–2032
3.3 Global Loxoprofen API (Sodium Salt) Revenue by Region: 2021–2032
3.3.1 Global Loxoprofen API (Sodium Salt) Revenue by Region: 2021–2026
3.3.2 Global Loxoprofen API (Sodium Salt) Revenue by Region: 2027–2032
3.4 North America Loxoprofen API (Sodium Salt) Market Facts & Figures by Country
3.4.1 North America Loxoprofen API (Sodium Salt) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Loxoprofen API (Sodium Salt) Sales by Country (2021–2032)
3.4.3 North America Loxoprofen API (Sodium Salt) Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Loxoprofen API (Sodium Salt) Market Facts & Figures by Country
3.5.1 Europe Loxoprofen API (Sodium Salt) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Loxoprofen API (Sodium Salt) Sales by Country (2021–2032)
3.5.3 Europe Loxoprofen API (Sodium Salt) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Loxoprofen API (Sodium Salt) Market Facts & Figures by Region
3.6.1 Asia Pacific Loxoprofen API (Sodium Salt) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Loxoprofen API (Sodium Salt) Sales by Region (2021–2032)
3.6.3 Asia Pacific Loxoprofen API (Sodium Salt) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Loxoprofen API (Sodium Salt) Market Facts & Figures by Country
3.7.1 Latin America Loxoprofen API (Sodium Salt) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Loxoprofen API (Sodium Salt) Sales by Country (2021–2032)
3.7.3 Latin America Loxoprofen API (Sodium Salt) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Loxoprofen API (Sodium Salt) Market Facts & Figures by Country
3.8.1 Middle East and Africa Loxoprofen API (Sodium Salt) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Loxoprofen API (Sodium Salt) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Loxoprofen API (Sodium Salt) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Loxoprofen API (Sodium Salt) Sales by Type (2021–2032)
4.1.1 Global Loxoprofen API (Sodium Salt) Sales by Type (2021–2026)
4.1.2 Global Loxoprofen API (Sodium Salt) Sales by Type (2027–2032)
4.1.3 Global Loxoprofen API (Sodium Salt) Sales Market Share by Type (2021–2032)
4.2 Global Loxoprofen API (Sodium Salt) Revenue by Type (2021–2032)
4.2.1 Global Loxoprofen API (Sodium Salt) Revenue by Type (2021–2026)
4.2.2 Global Loxoprofen API (Sodium Salt) Revenue by Type (2027–2032)
4.2.3 Global Loxoprofen API (Sodium Salt) Revenue Market Share by Type (2021–2032)
4.3 Global Loxoprofen API (Sodium Salt) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Loxoprofen API (Sodium Salt) Sales by Application (2021–2032)
5.1.1 Global Loxoprofen API (Sodium Salt) Sales by Application (2021–2026)
5.1.2 Global Loxoprofen API (Sodium Salt) Sales by Application (2027–2032)
5.1.3 Global Loxoprofen API (Sodium Salt) Sales Market Share by Application (2021–2032)
5.2 Global Loxoprofen API (Sodium Salt) Revenue by Application (2021–2032)
5.2.1 Global Loxoprofen API (Sodium Salt) Revenue by Application (2021–2026)
5.2.2 Global Loxoprofen API (Sodium Salt) Revenue by Application (2027–2032)
5.2.3 Global Loxoprofen API (Sodium Salt) Revenue Market Share by Application (2021–2032)
5.3 Global Loxoprofen API (Sodium Salt) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Daiichi Sankyo
6.1.1 Daiichi Sankyo Company Information
6.1.2 Daiichi Sankyo Description and Business Overview
6.1.3 Daiichi Sankyo Loxoprofen API (Sodium Salt) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Daiichi Sankyo Loxoprofen API (Sodium Salt) Product Portfolio
6.1.5 Daiichi Sankyo Recent Developments/Updates
6.2 Anlon Healthcare
6.2.1 Anlon Healthcare Company Information
6.2.2 Anlon Healthcare Description and Business Overview
6.2.3 Anlon Healthcare Loxoprofen API (Sodium Salt) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Anlon Healthcare Loxoprofen API (Sodium Salt) Product Portfolio
6.2.5 Anlon Healthcare Recent Developments/Updates
6.3 Metrochem
6.3.1 Metrochem Company Information
6.3.2 Metrochem Description and Business Overview
6.3.3 Metrochem Loxoprofen API (Sodium Salt) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Metrochem Loxoprofen API (Sodium Salt) Product Portfolio
6.3.5 Metrochem Recent Developments/Updates
6.4 Shinpoong Pharm
6.4.1 Shinpoong Pharm Company Information
6.4.2 Shinpoong Pharm Description and Business Overview
6.4.3 Shinpoong Pharm Loxoprofen API (Sodium Salt) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Shinpoong Pharm Loxoprofen API (Sodium Salt) Product Portfolio
6.4.5 Shinpoong Pharm Recent Developments/Updates
6.5 Apeloa Pharmaceutical
6.5.1 Apeloa Pharmaceutical Company Information
6.5.2 Apeloa Pharmaceutical Description and Business Overview
6.5.3 Apeloa Pharmaceutical Loxoprofen API (Sodium Salt) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Apeloa Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio
6.5.5 Apeloa Pharmaceutical Recent Developments/Updates
6.6 Luoxin Pharmaceutical
6.6.1 Luoxin Pharmaceutical Company Information
6.6.2 Luoxin Pharmaceutical Description and Business Overview
6.6.3 Luoxin Pharmaceutical Loxoprofen API (Sodium Salt) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Luoxin Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio
6.6.5 Luoxin Pharmaceutical Recent Developments/Updates
6.7 Hunan Jiudian Hongyang
6.7.1 Hunan Jiudian Hongyang Company Information
6.7.2 Hunan Jiudian Hongyang Description and Business Overview
6.7.3 Hunan Jiudian Hongyang Loxoprofen API (Sodium Salt) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hunan Jiudian Hongyang Loxoprofen API (Sodium Salt) Product Portfolio
6.7.5 Hunan Jiudian Hongyang Recent Developments/Updates
6.8 Zhejiang Starry Pharmaceutical
6.8.1 Zhejiang Starry Pharmaceutical Company Information
6.8.2 Zhejiang Starry Pharmaceutical Description and Business Overview
6.8.3 Zhejiang Starry Pharmaceutical Loxoprofen API (Sodium Salt) Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Zhejiang Starry Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio
6.8.5 Zhejiang Starry Pharmaceutical Recent Developments/Updates
6.9 Dongyue Pharma
6.9.1 Dongyue Pharma Company Information
6.9.2 Dongyue Pharma Description and Business Overview
6.9.3 Dongyue Pharma Loxoprofen API (Sodium Salt) Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Dongyue Pharma Loxoprofen API (Sodium Salt) Product Portfolio
6.9.5 Dongyue Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Loxoprofen API (Sodium Salt) Industry Chain Analysis
7.2 Loxoprofen API (Sodium Salt) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Loxoprofen API (Sodium Salt) Production Mode & Process Analysis
7.4 Loxoprofen API (Sodium Salt) Sales and Marketing
7.4.1 Loxoprofen API (Sodium Salt) Sales Channels
7.4.2 Loxoprofen API (Sodium Salt) Distributors
7.5 Loxoprofen API (Sodium Salt) Customer Analysis
8 Loxoprofen API (Sodium Salt) Market Dynamics
8.1 Loxoprofen API (Sodium Salt) Industry Trends
8.2 Loxoprofen API (Sodium Salt) Market Drivers
8.3 Loxoprofen API (Sodium Salt) Market Challenges
8.4 Loxoprofen API (Sodium Salt) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Daiichi Sankyo
Anlon Healthcare
Metrochem
Shinpoong Pharm
Apeloa Pharmaceutical
Luoxin Pharmaceutical
Zhejiang Starry Pharmaceutical
Dongyue Pharma
Hunan Jiudian Hongyang
List of Tables
 Table 1. Global Loxoprofen API (Sodium Salt) Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Loxoprofen API (Sodium Salt) Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Loxoprofen API (Sodium Salt) Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Loxoprofen API (Sodium Salt) Sales (Tons) of Key Manufacturers (2021–2026)
 Table 5. Global Loxoprofen API (Sodium Salt) Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Loxoprofen API (Sodium Salt) Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Loxoprofen API (Sodium Salt) Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Loxoprofen API (Sodium Salt) Average Price (US$/Kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Loxoprofen API (Sodium Salt), Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Loxoprofen API (Sodium Salt), Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Loxoprofen API (Sodium Salt), Product Types and Applications
 Table 12. Global Key Manufacturers of Loxoprofen API (Sodium Salt), Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Loxoprofen API (Sodium Salt) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Loxoprofen API (Sodium Salt) Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Loxoprofen API (Sodium Salt) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Loxoprofen API (Sodium Salt) Sales by Region (Tons), 2021–2026
 Table 18. Global Loxoprofen API (Sodium Salt) Sales Market Share by Region (2021–2026)
 Table 19. Global Loxoprofen API (Sodium Salt) Sales by Region (Tons), 2027–2032
 Table 20. Global Loxoprofen API (Sodium Salt) Sales Market Share by Region (2027–2032)
 Table 21. Global Loxoprofen API (Sodium Salt) Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Loxoprofen API (Sodium Salt) Revenue Market Share by Region (2021–2026)
 Table 23. Global Loxoprofen API (Sodium Salt) Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Loxoprofen API (Sodium Salt) Revenue Market Share by Region (2027–2032)
 Table 25. North America Loxoprofen API (Sodium Salt) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Loxoprofen API (Sodium Salt) Sales by Country (Tons), 2021–2026
 Table 27. North America Loxoprofen API (Sodium Salt) Sales by Country (Tons), 2027–2032
 Table 28. North America Loxoprofen API (Sodium Salt) Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Loxoprofen API (Sodium Salt) Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Loxoprofen API (Sodium Salt) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Loxoprofen API (Sodium Salt) Sales by Country (Tons), 2021–2026
 Table 32. Europe Loxoprofen API (Sodium Salt) Sales by Country (Tons), 2027–2032
 Table 33. Europe Loxoprofen API (Sodium Salt) Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Loxoprofen API (Sodium Salt) Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Loxoprofen API (Sodium Salt) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Loxoprofen API (Sodium Salt) Sales by Region (Tons), 2021–2026
 Table 37. Asia Pacific Loxoprofen API (Sodium Salt) Sales by Region (Tons), 2027–2032
 Table 38. Asia Pacific Loxoprofen API (Sodium Salt) Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Loxoprofen API (Sodium Salt) Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Loxoprofen API (Sodium Salt) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Loxoprofen API (Sodium Salt) Sales by Country (Tons), 2021–2026
 Table 42. Latin America Loxoprofen API (Sodium Salt) Sales by Country (Tons), 2027–2032
 Table 43. Latin America Loxoprofen API (Sodium Salt) Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Loxoprofen API (Sodium Salt) Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Loxoprofen API (Sodium Salt) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Loxoprofen API (Sodium Salt) Sales by Country (Tons), 2021–2026
 Table 47. Middle East and Africa Loxoprofen API (Sodium Salt) Sales by Country (Tons), 2027–2032
 Table 48. Middle East and Africa Loxoprofen API (Sodium Salt) Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Loxoprofen API (Sodium Salt) Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Loxoprofen API (Sodium Salt) Sales (Tons) by Type (2021–2026)
 Table 51. Global Loxoprofen API (Sodium Salt) Sales (Tons) by Type (2027–2032)
 Table 52. Global Loxoprofen API (Sodium Salt) Sales Market Share by Type (2021–2026)
 Table 53. Global Loxoprofen API (Sodium Salt) Sales Market Share by Type (2027–2032)
 Table 54. Global Loxoprofen API (Sodium Salt) Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Loxoprofen API (Sodium Salt) Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Loxoprofen API (Sodium Salt) Revenue Market Share by Type (2021–2026)
 Table 57. Global Loxoprofen API (Sodium Salt) Revenue Market Share by Type (2027–2032)
 Table 58. Global Loxoprofen API (Sodium Salt) Price (US$/Kg) by Type (2021–2026)
 Table 59. Global Loxoprofen API (Sodium Salt) Price (US$/Kg) by Type (2027–2032)
 Table 60. Global Loxoprofen API (Sodium Salt) Sales (Tons) by Application (2021–2026)
 Table 61. Global Loxoprofen API (Sodium Salt) Sales (Tons) by Application (2027–2032)
 Table 62. Global Loxoprofen API (Sodium Salt) Sales Market Share by Application (2021–2026)
 Table 63. Global Loxoprofen API (Sodium Salt) Sales Market Share by Application (2027–2032)
 Table 64. Global Loxoprofen API (Sodium Salt) Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Loxoprofen API (Sodium Salt) Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Loxoprofen API (Sodium Salt) Revenue Market Share by Application (2021–2026)
 Table 67. Global Loxoprofen API (Sodium Salt) Revenue Market Share by Application (2027–2032)
 Table 68. Global Loxoprofen API (Sodium Salt) Price (US$/Kg) by Application (2021–2026)
 Table 69. Global Loxoprofen API (Sodium Salt) Price (US$/Kg) by Application (2027–2032)
 Table 70. Daiichi Sankyo Company Information
 Table 71. Daiichi Sankyo Description and Business Overview
 Table 72. Daiichi Sankyo Loxoprofen API (Sodium Salt) Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 73. Daiichi Sankyo Loxoprofen API (Sodium Salt) Product
 Table 74. Daiichi Sankyo Recent Developments/Updates
 Table 75. Anlon Healthcare Company Information
 Table 76. Anlon Healthcare Description and Business Overview
 Table 77. Anlon Healthcare Loxoprofen API (Sodium Salt) Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 78. Anlon Healthcare Loxoprofen API (Sodium Salt) Product
 Table 79. Anlon Healthcare Recent Developments/Updates
 Table 80. Metrochem Company Information
 Table 81. Metrochem Description and Business Overview
 Table 82. Metrochem Loxoprofen API (Sodium Salt) Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 83. Metrochem Loxoprofen API (Sodium Salt) Product
 Table 84. Metrochem Recent Developments/Updates
 Table 85. Shinpoong Pharm Company Information
 Table 86. Shinpoong Pharm Description and Business Overview
 Table 87. Shinpoong Pharm Loxoprofen API (Sodium Salt) Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 88. Shinpoong Pharm Loxoprofen API (Sodium Salt) Product
 Table 89. Shinpoong Pharm Recent Developments/Updates
 Table 90. Apeloa Pharmaceutical Company Information
 Table 91. Apeloa Pharmaceutical Description and Business Overview
 Table 92. Apeloa Pharmaceutical Loxoprofen API (Sodium Salt) Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 93. Apeloa Pharmaceutical Loxoprofen API (Sodium Salt) Product
 Table 94. Apeloa Pharmaceutical Recent Developments/Updates
 Table 95. Luoxin Pharmaceutical Company Information
 Table 96. Luoxin Pharmaceutical Description and Business Overview
 Table 97. Luoxin Pharmaceutical Loxoprofen API (Sodium Salt) Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 98. Luoxin Pharmaceutical Loxoprofen API (Sodium Salt) Product
 Table 99. Luoxin Pharmaceutical Recent Developments/Updates
 Table 100. Hunan Jiudian Hongyang Company Information
 Table 101. Hunan Jiudian Hongyang Description and Business Overview
 Table 102. Hunan Jiudian Hongyang Loxoprofen API (Sodium Salt) Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 103. Hunan Jiudian Hongyang Loxoprofen API (Sodium Salt) Product
 Table 104. Hunan Jiudian Hongyang Recent Developments/Updates
 Table 105. Zhejiang Starry Pharmaceutical Company Information
 Table 106. Zhejiang Starry Pharmaceutical Description and Business Overview
 Table 107. Zhejiang Starry Pharmaceutical Loxoprofen API (Sodium Salt) Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 108. Zhejiang Starry Pharmaceutical Loxoprofen API (Sodium Salt) Product
 Table 109. Zhejiang Starry Pharmaceutical Recent Developments/Updates
 Table 110. Dongyue Pharma Company Information
 Table 111. Dongyue Pharma Description and Business Overview
 Table 112. Dongyue Pharma Loxoprofen API (Sodium Salt) Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 113. Dongyue Pharma Loxoprofen API (Sodium Salt) Product
 Table 114. Dongyue Pharma Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Loxoprofen API (Sodium Salt) Distributors List
 Table 118. Loxoprofen API (Sodium Salt) Customers List
 Table 119. Loxoprofen API (Sodium Salt) Market Trends
 Table 120. Loxoprofen API (Sodium Salt) Market Drivers
 Table 121. Loxoprofen API (Sodium Salt) Market Challenges
 Table 122. Loxoprofen API (Sodium Salt) Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Loxoprofen API (Sodium Salt)
 Figure 2. Global Loxoprofen API (Sodium Salt) Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Loxoprofen API (Sodium Salt) Market Share by Type: 2025 & 2032
 Figure 4. Purity ≥99% Product Picture
 Figure 5. Purity <99% Product Picture
 Figure 6. Global Loxoprofen API (Sodium Salt) Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Loxoprofen API (Sodium Salt) Market Share by Application: 2025 & 2032
 Figure 8. Oral Preparations
 Figure 9. Topical Preparations
 Figure 10. Global Loxoprofen API (Sodium Salt) Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Loxoprofen API (Sodium Salt) Market Size (US$ Million), 2021–2032
 Figure 12. Global Loxoprofen API (Sodium Salt) Sales (Tons), 2021–2032
 Figure 13. Global Loxoprofen API (Sodium Salt) Average Price (US$/Kg), 2021–2032
 Figure 14. Loxoprofen API (Sodium Salt) Report Years Considered
 Figure 15. Loxoprofen API (Sodium Salt) Sales Share by Manufacturers in 2025
 Figure 16. Global Loxoprofen API (Sodium Salt) Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Loxoprofen API (Sodium Salt) Players: Market Share by Revenue in Loxoprofen API (Sodium Salt) in 2025
 Figure 18. Loxoprofen API (Sodium Salt) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Loxoprofen API (Sodium Salt) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Loxoprofen API (Sodium Salt) Sales Market Share by Country (2021–2032)
 Figure 21. North America Loxoprofen API (Sodium Salt) Revenue Market Share by Country (2021–2032)
 Figure 22. United States Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Loxoprofen API (Sodium Salt) Sales Market Share by Country (2021–2032)
 Figure 25. Europe Loxoprofen API (Sodium Salt) Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Loxoprofen API (Sodium Salt) Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Loxoprofen API (Sodium Salt) Revenue Market Share by Region (2021–2032)
 Figure 33. China Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Loxoprofen API (Sodium Salt) Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Loxoprofen API (Sodium Salt) Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Colombia Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Loxoprofen API (Sodium Salt) Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Loxoprofen API (Sodium Salt) Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Loxoprofen API (Sodium Salt) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Loxoprofen API (Sodium Salt) by Type (2021–2032)
 Figure 52. Global Revenue Market Share of Loxoprofen API (Sodium Salt) by Type (2021–2032)
 Figure 53. Global Loxoprofen API (Sodium Salt) Price (US$/Kg) by Type (2021–2032)
 Figure 54. Global Sales Market Share of Loxoprofen API (Sodium Salt) by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Loxoprofen API (Sodium Salt) by Application (2021–2032)
 Figure 56. Global Loxoprofen API (Sodium Salt) Price (US$/Kg) by Application (2021–2032)
 Figure 57. Loxoprofen API (Sodium Salt) Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions